Core Viewpoint - Basel Medical Group Ltd has received notification from Nasdaq regarding the incompleteness of its annual report for the fiscal year ended June 30, 2025, due to the absence of an auditor's opinion on its financial statements [1] Compliance and Remediation - The Company has 60 calendar days to submit a plan to regain compliance with Nasdaq rules, which may allow for an extension of up to 180 calendar days to meet filing obligations [2] - Nasdaq will evaluate the compliance plan based on factors such as the likelihood of timely filing, the Company's past compliance history, and its overall financial condition [2] - The Company is currently collaborating with accounting, audit, and legal professionals to prepare a rectification plan for the noted non-compliance [3] Company Overview - Basel Medical Group is a Singapore-based provider of various medical services, including orthopedic and trauma services, sports medicine, and neurosurgical treatments [4] - The Company has established strong relationships with corporations, particularly in the construction, marine, and oil & gas industries, supporting its business model [4] - The Company is well-positioned to capitalize on growth opportunities in the private healthcare sector in Singapore and Southeast Asia, driven by factors such as an aging population and increasing healthcare expenditure [4]
Receipt of Delinquency Notification from Nasdaq